This suggests that, in our cohort, patients with diabetes (who were more likely to exhibit severe CAD) had plasma Lp(a) levels that more closely resembled the underlying population distribution, whereas patients without diabetes were more likely to have high Lp(a) as a driver of CAD. This evidence concerns the gene LPA and diabetes mellitus.